Board of Directors
Company Risk
Underperformance of investment projects may affect growth targets, return on investment, investor confidence, and long-term value creation.
The Company applies rigorous financial and business analysis prior to investment decisions and conducts ongoing performance reviews. Significant matters are periodically reported to the RMC to enable timely review and adjustment where appropriate.
Non-compliance may result in penalties, legal proceedings, operational restrictions, and reputational impact. Based on current assessment, such risks remain manageable under the Company’s governance and compliance framework.
The Company maintains robust internal control and compliance monitoring systems. Legal advisors are consulted on significant matters, and employees receive regular updates on regulatory requirements. Material issues are reported to management and the RMC on a periodic basis.
If the Company is unable to appropriately manage its liquidity or capital structure, it may affect its financial flexibility, its ability to meet obligations and undertake new projects, as well as its cost of funding. Such circumstances could have an adverse impact on operating results and the confidence of investors or financial institutions. However, based on the Company’s assessment, such risk remains at a manageable level, subject to close monitoring by the management team and the relevant committees
The Company prepares both short-term and medium-term cash flow projections and regularly monitors its liquidity position, debt obligations, and key financial ratios. The Company also periodically reports its financial status to the management team and the Risk Management Committee to enable the timely determination of appropriate mitigating measures and to maintain the Company’s financial stability on an ongoing basis.
If the Company is unable to effectively manage its operational processes and resources, it may affect service efficiency, business continuity, cost levels, and patient satisfaction, which could in turn have an impact on the Company’s overall operating performance. Nevertheless, the Company assesses that such risk remains at a manageable level under its existing monitoring and governance framework
The Company plans its workforce in alignment with the volume and complexity of patients and closely monitors the availability of medical doctors and nursing personnel. Physicians are allocated and rotated within the hospital network by region to enhance flexibility in resource management, and nursing staff are appropriately assigned to units where operational needs are most critical. In addition, the Company has established Operational Key Performance Indicators (KPIs) covering service quality, resource utilization, and cost control. Operating results are reported to the management team and the Risk Management Committee on a quarterly basis to enable the timely implementation of improvement measures and to maintain consistent operational standards on an ongoing basis.
If incidents affecting the quality of care or patient safety were to occur, they could have an adverse impact on the Company’s reputation, the confidence of patients and stakeholders, and may result in financial burdens arising from compensation or legal proceedings. However, based on ongoing monitoring and assessment, the Company considers that such risks are subject to appropriate control systems and remain manageable.
The Company systematically establishes and monitors quality and patient safety indicators. Incident reporting is implemented, and in-depth Root Cause Analysis is conducted to prevent recurrence, together with the continuous implementation of process improvement measures. Significant matters are periodically reported to the management team and the Risk Management Committee. In addition, the Company has arranged Medical Malpractice Insurance to manage potential financial impacts and encourages physicians and medical personnel to obtain appropriate professional liability insurance coverage, thereby enhancing stability and confidence in the performance of their duties.
If such ESG risks materialize, they may affect the Company in several dimensions, including disruptions to hospital operations, continuity of the supply chain, increased energy costs or investments in environmental infrastructure, as well as legal and regulatory compliance risks. From a social perspective, incidents related to human rights violations, patient complaints, or issues concerning the quality of medical services may affect the Company’s reputation, patients’ confidence, and relationships with stakeholders. At the same time, ESG risks within the supply chain, such as suppliers’ operations that do not align with environmental or human rights standards, may affect the Company’s reputation, the continuity of medical supply procurement, and investor confidence.
The Company places importance on the management of ESG risks under the framework of good corporate governance. Environmental, social, and governance issues are continuously monitored, including assessments of climate change impacts over the short, medium, and long term. The Company has implemented measures to enhance energy efficiency, appropriately manage medical waste, and improve the efficient use of resources. At the same time, the Company monitors trends in environmental measures and carbon-related policies that may affect future business operations. In addition, the Company has initiated the development of processes to assess climate change risks at the location level by considering climate-related and disaster factors that may occur in each area where the Company operates. This is to assess the risks and vulnerabilities of hospitals under different climate scenario analyses, such as a scenario in which global temperature rise is limited to 1.5 Celsius and a scenario in which global temperatures continue to increase. The results of such assessments will be used in risk management planning, infrastructure adaptation, and long-term operational preparedness. The Company is also preparing to enhance sustainability and climate-related risk disclosures in alignment with international disclosure standards, such as the IFRS Sustainability Disclosure Standards (IFRS S1 and IFRS S2), as well as other relevant climate-related disclosure frameworks. This is to ensure transparency in disclosures, alignment with international best practices, and responsiveness to the expectations of investors and stakeholders. On the social aspect, the Company places importance on the protection of human rights, equitable access to medical services, and the provision of appropriate working environments for personnel. The Company has initiated Human Rights Due Diligence in accordance with international standards in order to assess human rights risks that may affect patients, personnel, suppliers, and stakeholders throughout the value chain. The Company has conducted a pilot project in five hospitals within its network to assess human rights risk issues and determine appropriate management approaches. There are plans to expand such implementation to other hospitals within the network on a continuous basis in order to strengthen the organization-wide human rights risk management system. Meanwhile, on the governance aspect, the Company places importance on overseeing suppliers and the supply chain to ensure alignment with legal, ethical, and sustainability standards. The Company also maintains a strong internal audit process to mitigate corruption risks and has established a whistleblowing process that has been communicated both internally and externally. Based on the Company’s assessment, ESG risks remain at a manageable level under the Company’s corporate governance, risk management, and internal control systems. The Company will continue to monitor and review these risk issues on an ongoing basis in order to enhance preparedness in managing risks and to support sustainable business operations in the long term.
Shareholder Risk
The shareholding structure of the Viddayakorn Group allows them to effectively control the Company and exert significant influence over decisions that require shareholder approval. This includes matters such as the appointment of directors, approval of business strategies, dividend policies, or any other resolutions requiring a simple majority vote at the shareholders’ meeting. The only exceptions are matters for which the law or the Company’s Articles of Association require a supermajority—specifically, at least three-quarters of the shareholders’ votes—to approve. As a result, minority shareholders face the risk of being unable to collectively muster sufficient voting power to review, challenge, or balance proposals put forward by the Viddayakorn Group at shareholders’ meetings. This concentration of voting power may limit the ability of minority shareholders to influence key corporate decisions, potentially affecting corporate governance, transparency, and the alignment of the Company’s strategic direction with the interests of all shareholders. Consequently, minority shareholders must rely on existing regulatory safeguards, disclosure requirements, and the oversight of the Board of Directors to ensure that the Company’s operations are conducted fairly and in compliance with good corporate governance practices.
The Company has established governance structures by appointing six external individuals as independent directors and three individuals as audit committee members, out of a total of 12 directors. This structure helps provide a level of balance and checks on the Company’s management authority. The independent directors and audit committee members perform oversight functions independently, ensuring that decisions made by the Board are conducted with due diligence, transparency, and in alignment with the interests of all shareholders. In addition, the Company has established strict governance measures for transactions involving related parties, including directors, major shareholders, or persons with controlling power. Such individuals are not entitled to vote on the approval of these transactions, which enhances transparency, mitigates potential conflicts of interest, and reinforces confidence among minority shareholders and other stakeholders that key corporate decisions are conducted fairly and equitably. Overall, this governance structure not only serves to balance authority within the Company but also reflects the Company’s commitment to good corporate governance and to building long-term confidence among all shareholders and stakeholders.
Unlock full benchmarking
Claim this company to see every KPI your sector qualifies for, from 70+ across the market, benchmarked against sector peers.

